Immunotherapy against lung cancer does not need to compromise the outcomes of COVID-19.

Jiadi GanJiaxuan WuHuohuo ZhangDan LiuWeimin Li

Published in: MedComm (2023)

Keyphrases

coronavirus disease
sars cov
type diabetes
metabolic syndrome
skeletal muscle
glycemic control
insulin resistance